OncoStem eyes wider access to breast cancer risk test with hospital-use kit

OncoStem, a Bengaluru company, has raised around $9 million from Artiman Ventures and Sequoia Capital India. The firm is making its breast cancer risk test easier to access with a hospital-use kit. Because the test can now be done at hospitals instead of central labs, logistical barriers drop. OncoStem expects annual volumes to double, opening the door to personalised treatment for more patients.